Alzheimer; News from the web:

FDA has granted breakthrough status to two medical devices aimed at Alzheimer’s disease patients in its latest batch of designations. The agency also awarded regulatory privileges to a clutch of device developers hoping to compete for the cardiovascular disease market.

Read all about it HERE